Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome

Haematologica. 2022 Nov 1;107(11):2737-2741. doi: 10.3324/haematol.2022.281586.

Authors

Igor Giarretta¹, Walter Ageno², Francesco Dentali³

Affiliations

¹ Department of Emergency of High-Specialty and Medical Center, ASST-Settelaghi, Varese.
² Department of Medicine and Surgery, University of Insubria, Varese.
³ Department of Emergency of High-Specialty and Medical Center, ASST-Settelaghi, Varese, Italy; Department of Medicine and Surgery, University of Insubria, Varese. francesco.dentali@asst-settelaghi.it.

No abstract available

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use
Antiphospholipid Syndrome* / drug therapy
Humans
Rivaroxaban / therapeutic use
Warfarin* / therapeutic use

Substances

Warfarin
Anticoagulants
Rivaroxaban